Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
138.6 USD | +0.30% |
|
+0.80% | +5.32% |
07-03 | ANALYST RECOMMENDATIONS : Alphabet, Nike, Nvidia, Tesla, Starbucks... | ![]() |
07-03 | Neurocrine Biosciences Insider Sold Shares Worth $1,401,864, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.32% | 13.91B | |
+16.89% | 121B | |
+17.57% | 110B | |
+17.23% | 25.98B | |
-24.65% | 19.27B | |
-18.56% | 15.99B | |
-18.60% | 15.66B | |
-47.75% | 14.5B | |
+56.94% | 14.47B | |
+117.25% | 10B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Neurocrine Biosciences Says US FDA Accepts NDAs With Priority Review for Adrenal Gland Disease Drug